| Computer-aided prediction of pharmacokinetic (ADMET) properties B Chandrasekaran, SN Abed, O Al-Attraqchi, K Kuche, RK Tekade Dosage form design parameters, 731-755, 2018 | 210 | 2018 |
| Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer S Mahajan, A Patharkar, K Kuche, R Maheshwari, PK Deb, K Kalia, ... International journal of pharmaceutics 548 (1), 540-558, 2018 | 147 | 2018 |
| Cell-penetrating peptides (CPPs): An overview of applications for improving the potential of nanotherapeutics K Desale, K Kuche, S Jain Biomaterials Science 9 (4), 1153-1188, 2021 | 107 | 2021 |
| Drug-phospholipid complex—a go through strategy for enhanced oral bioavailability K Kuche, N Bhargavi, CP Dora, S Jain AAPS PharmSciTech 20 (2), 43, 2019 | 94 | 2019 |
| Chondroitin Sulfate: Emerging biomaterial for biopharmaceutical purpose and tissue engineering R Sharma, K Kuche, P Thakor, V Bhavana, S Srivastava, NK Mehra, ... Carbohydrate Polymers 286, 119305, 2022 | 90 | 2022 |
| Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential K Kuche, R Maheshwari, V Tambe, KK Mak, H Jogi, N Raval, MR Pichika, ... Nanoscale 10 (19), 8911-8937, 2018 | 76 | 2018 |
| Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy S Jain, SV Deore, R Ghadi, D Chaudhari, K Kuche, SS Katiyar Materials Science and Engineering: C 121, 111832, 2021 | 59 | 2021 |
| pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel R Swami, Y Kumar, D Chaudhari, SS Katiyar, K Kuche, PB Katare, ... Materials Science and Engineering: C 120, 111664, 2021 | 56 | 2021 |
| Carbon nanotubes in the delivery of anticancer herbal drugs H Jogi, R Maheshwari, N Raval, K Kuche, V Tambe, KK Mak, MR Pichika, ... Nanomedicine 13 (10), 1187-1220, 2018 | 39 | 2018 |
| Dosage form design parameters B Chandrasekaran, SN Abed, O Al-Attraqchi, K Kuche, RK Tekade Elsevier, 2018 | 39 | 2018 |
| Exploring the promising potential of high permeation vesicle-mediated localized transdermal delivery of docetaxel in breast cancer to overcome the limitations of systemic … M Bathara, T Date, D Chaudhari, R Ghadi, K Kuche, S Jain Molecular pharmaceutics 17 (7), 2473-2486, 2020 | 35 | 2020 |
| Exploring the potential of novel pH sensitive lipoplexes for tumor targeted gene delivery with reduced toxicity Y Kumar, K Kuche, R Swami, SS Katiyar, D Chaudhari, PB Katare, ... International Journal of Pharmaceutics 573, 118889, 2020 | 33 | 2020 |
| Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance L Kaushik, S Srivastava, A Panjeta, D Chaudhari, R Ghadi, K Kuche, ... International Journal of Pharmaceutics 578, 119088, 2020 | 31 | 2020 |
| Recent advances in lipid-based long-acting injectable depot formulations R Sharma, S Yadav, V Yadav, J Akhtar, O Katari, K Kuche, S Jain Advanced drug delivery reviews 199, 114901, 2023 | 29 | 2023 |
| Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer D Chaudhari, K Kuche, V Yadav, R Ghadi, T Date, N Bhargavi, S Jain Drug delivery and translational research 13 (4), 1074-1087, 2023 | 26 | 2023 |
| Supersaturable self-emulsifying drug delivery system: a strategy for improving the loading and oral bioavailability of quercetin A Sirvi, K Kuche, D Chaudhari, R Ghadi, T Date, SS Katiyar, S Jain Journal of Drug Delivery Science and Technology 71, 103289, 2022 | 26 | 2022 |
| A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer N Malavia, K Kuche, R Ghadi, S Jain Journal of Controlled Release 330, 72-100, 2021 | 24 | 2021 |
| Micromeritics in pharmaceutical product development R Maheshwari, P Todke, K Kuche, N Raval, RK Tekade Dosage form design considerations, 599-635, 2018 | 23 | 2018 |
| Unfolding the potency of adenosine in targeting triple negative breast cancer via paclitaxel-incorporated pH-responsive stealth liposomes D Chaudhari, O Katari, R Ghadi, K Kuche, T Date, N Bhargavi, S Jain ACS Biomaterials Science & Engineering 8 (8), 3473-3484, 2022 | 20 | 2022 |
| Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: a dual-death therapy for triple negative breast cancer R Ghadi, PK Pandey, A Gabhale, A Wadikar, M Dharshini, K Kuche, ... International Journal of Pharmaceutics 648, 123570, 2023 | 17 | 2023 |
Rahul Maheshwari (Postdoc NUS Sin...NMIMS University, Hyderabad # NUS Singapore# NIPER-AE-mail megerősítve itt: nmims.edu